Surgical procedures for uterine sarcoma;Chirurgie des sarcomes utérins: Revue de la littérature et recommandations sur la prise en charge chirurgicale

Gynecologie Obstetrique et Fertilite

Volumn 31, Issue 2, 2003, Pages 147-150

  Morice, P ^a   Rodrigues, A ^a   Pautier, P ^a   Rey, A ^a   Camatte, S ^a   Atallah, D ^a   Pomel, C ^a   Lhomme C ^a   Haie Meder, C ^a   Duvillard, P ^a   Castaigne, D ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Adnexectomy; Hysterectomy; Laparotomy; Lymphadenectomy; Omentectomy; Uterine sarcoma

Indexed keywords

CARCINOSARCOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LAPAROTOMY; LYMPH NODE HYPERPLASIA; LYMPHADENECTOMY; OMENTOPLASTY; OMENTUM; REVIEW; RISK MANAGEMENT; SALPINGOOOPHORECTOMY; STANDARD; SURGICAL APPROACH; SURGICAL RISK; UTERINE PARCELLING; UTERUS SARCOMA;

EID: 0038637704     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(03)00061-4     Document Type: Review

References (27)

1. Pautier P, Genestie C, Rey A, Morice P, Roche B, Lhommé C, Haie-Meder C, Duvillard P. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft-tissue sarcoma. Cancer 2000;88:1425.
2. Schwartz LB, Diamond MP, Schwartz PE. Leiomyosarcomas: clinical presentation. Am J Obstet Gynecol 1993;168:180-3.
3. Kawamura N, Ichimura T, Ito F, Shibata S, Takahashi K, Tsujimura A, Ishiko O, Haba T, Wakasa K, Ogita S. Transcervical needle biopsy for the differential diagnosis between uterine sarcoma and leiomyoma. Cancer 2002;94:1713-20.
4. Singer S, Corson JM, Demetri GD, Healey EA, Marcus K, Eberlein TJ. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissuesarcoma. Ann Surg 1995;221:185.
5. Jaques DP, Coit DG, Hajdu SI, Brennan MF. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg 1990;212(51).
6. Dalton R, Donahue J, Mucha P. Management of retroperitoneal softtissue sarcoma. Ann Surg 1991;213:2610.
7. Coquard R, Romestaing P, Ardiet JM, Mornex F, Sentenac I, Gerard JP. Les sarcomes utérins traités par chirurgie et irradiation postopératoire. Mode de rechute, facteurs pronostiques, rôle de la radiothérapie. Bull Cancer 1997;84:625.
8. Morice P, Rodriguez A, Rey A, Pautier P, Atallah D, Genestie C, Lhommé C, Haie-Meder C, Duvillard P, Castaigne D. Prognostic value of initial surgical procedure for patients with uterine sarcoma: analysis of 123 patients. Eur J Gynecol Cancer 2003 (in press).
9. Piver M, Lurain JR. Uterine sarcomas: clinical features and management. In: Coppleson M, editor. Gynecologic Oncology, 2. London: Churcill Livingstone Editor; 1981.
10. Geszler G, Szpak CA, Harris RE, Creasman WT, Barter JF, Johnston WW. Prognostic value of peritoneal washings in patients with malignant mixed mullerian tumors of the uterus. Am J Obstet Gynecol 1986;155:83-9.
11. Wain G, Hacker N. Clinical features and treatment of genital sarcomas. In: Burghardt E, Webb M, Monaghan J, Kinderman G, editors. Surgical Gynecologic Oncology. New York: Georg Thieme Verlag Editor; 1993.
12. Michel G, Pfeiffer F, Duvillard P, Prade M, Castaigne D, Zarca D, Pejovic-Lenfant MH, Gerbaulet A, Lhomme C. Sarcomes utérins. Étude clinique à propos de 50 cas opérés à l'Institut Gustave Roussy Institute. Revue de la littérature. J Gynecol Obstet Biol Reprod 1989; 18:1024-30.
13. Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL. Treatment of endometrial stromal tumors. Gynecol Oncol 1990;36:60-5.
14. Practice guidelines: uterine corpus - sarcomas. Society of Gynecologic Oncologists Clinical Practice Guidelines. Oncology 1998;12:284-6.
15. Aaro LA, Symmonds RE, Dockerty MB. Sarcoma of the uterus. A clinical and pathologic study of 177 cases. Am J Obstet Gynecol 1966;94:101-9.
16. Taylor HB, Norris HJ. Mesenchymal tumors of the uterus. IV. Diagnosis and prognosis of leiomyosarcomas. Arch Pathol 1966;82:40-4.
17. Norris HJ, Taylor HB. Mesenchymal tumors of the uterus. 3. A clinical and pathologic study of 31 carcinosarcomas. Cancer 1966; 19:1459-65.
18. Chen SS. Propensity of retroperitoneal lymph node metastasis in patients with stage I sarcoma of the uterus. Gynecol Oncol 1989;32:215-7.
19. Goff BA, Rice LW, Fleischhacker D, Muntz HG, Falkenberry SS, Nikrui N, Fuller AF. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol 1993;50:105-9.
20. Podczaski ES, Woomert CA, Stevens CW, Manetta A, Larson JE, Zaino RJ, Mortel R. Management of malignant, mixed mesodermal tumors of the uterus. Gynecol Oncol 1989;32:240-4.
21. Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao SY, Miller A. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 1990;9:1-19.
22. Yamada SD, Burger RA, Brewster WR, Anton D, Kohler MF, Monk BJ. Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus. Cancer 2000;88:2782-6.
23. Van Dinh T, Woodruff JD. Leiomyosarcoma of the uterus. Am J Obstet Gynecol 1982;144:817-23.
24. Lissoni A, Cormio G, Bonazzi C, Perego P, Lomonico S, Gabriele A, Bratina G. Fertility-sparing surgery in uterine leiomyosarcoma. Gynecol Oncol 1998;70:348-50.
25. Lang H, Nussbaum KT, Kaudel P, Fruhauf N, Flemming P, Raab R. Hepatic metastases from leiomyosarcoma: A single-center experience with 34 liver resections during a 15-year period. Ann Surg 2000; 231:500-5.
26. Levenback C, Rubin SC, McCormack PM, Hoskins WJ, Atkinson EN, Lewis JL. Resection of pulmonary metastases from uterine sarcomas. Gynecol Oncol 1992;45:202-5.
27. Anderson TM, Mc Mahon JJ, Nwogu CE, Pombo MW, Urschel JD, Driscoll DL, Lele SB. Pulmonary resection in metastatic uterine and cervical malignancies. Gynecol Oncol 1991;83:472-6.